UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000053662 |
|---|---|
| Receipt number | R000061245 |
| Scientific Title | Development of blood circulation quantification method using small number of frame data in dynamic contrast-enhanced MRI of prostate cancer |
| Date of disclosure of the study information | 2024/03/01 |
| Last modified on | 2024/08/21 15:34:02 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Development of blood circulation quantification method using small number of frame data in dynamic contrast-enhanced MRI of prostate cancer
Acronym
Quantification of blood circulation for small number frame data in prostate DCE-MRI
Scientific Title
Development of blood circulation quantification method using small number of frame data in dynamic contrast-enhanced MRI of prostate cancer
Scientific Title:Acronym
Quantification of blood circulation for small number frame data in prostate DCE-MRI
Region
| Japan |
Condition
Condition
Prostate cancer
Classification by specialty
| Radiology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
The purpose of this study is to develop a method to precisely quantify blood circulation using a small number of frame data obtained from low temporal resolution or short length scans in dynamic contrast-enhanced MRI of prostate cancer.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Validity of blood circulation parameters derived from data with frame number reduction
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male
Key inclusion criteria
Patients who underwent dynamic contrast-enhanced, T2-weighted, and diffusion-weighted prostate MRI at our institution between March 2013 and November 2023.
Key exclusion criteria
Patients who refused secondary use of information at the time of informed consent
Patients who requested that their information not be used during the opt-out period
Target sample size
40
Research contact person
Name of lead principal investigator
| 1st name | Takayuki |
| Middle name | |
| Last name | Obata |
Organization
National Institutes for Quantum Science and Technology
Division name
Department of Molecular Imaging and Theranostics
Zip code
263-8555
Address
4-9-1, Anagawa, Inage-ku, Chiba
TEL
043-206-3230
obata.takayuki@qst.go.jp
Public contact
Name of contact person
| 1st name | Takayuki |
| Middle name | |
| Last name | Obata |
Organization
National Institutes for Quantum Science and Technology
Division name
Department of Molecular Imaging and Theranostics
Zip code
263-8555
Address
4-9-1, Anagawa, Inage-ku, Chiba
TEL
043-206-3230
Homepage URL
obata.takayuki@qst.go.jp
Sponsor or person
Institute
National Institutes for Quantum Science and Technology
Institute
Department
Personal name
Funding Source
Organization
National Institutes for Quantum Science and Technology
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
National Institutes for Quantum Science and Technology, Certified Review Board
Address
4-9-1, Anagawa, Inage-ku, Chiba
Tel
043-206-4709
helsinki@qst.go.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2024 | Year | 03 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
40
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
No longer recruiting
Date of protocol fixation
| 2024 | Year | 02 | Month | 14 | Day |
Date of IRB
| 2024 | Year | 02 | Month | 14 | Day |
Anticipated trial start date
| 2024 | Year | 03 | Month | 01 | Day |
Last follow-up date
| 2024 | Year | 05 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
This is a retrospective study.
Management information
Registered date
| 2024 | Year | 02 | Month | 20 | Day |
Last modified on
| 2024 | Year | 08 | Month | 21 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000061245
